BIOTRANSFORMATION OF FLUTICASONE: IN VITRO CHARACTERIZATION
Open Access
- 24 March 2006
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Drug Metabolism and Disposition
- Vol. 34 (6), 1035-1040
- https://doi.org/10.1124/dmd.105.009043
Abstract
Fluticasone propionate (FTP) is a synthetic trifluorinated glucocorticoid with potent anti-inflammatory action that is commonly used in patients with asthma. After oral or intranasal administration, FTP undergoes rapid hepatic biotransformation; the principal metabolite formed is a 17beta-carboxylic acid derivative (M1). M1 formation has been attributed largely to cytochrome P450 3A4 (CYP3A4); however, there are no published data that confirm this assertion. Hence, in vitro studies were conducted to determine the role that human P450s play in the metabolism of FTP. Consistent with in vivo data, human liver microsomes catalyzed the formation of a single metabolite (M1) at substrate concentrations 0.95) with CYP3A4/5 activities in a panel of human liver microsomes (n = 14) and was markedly impaired by the CYP3A inhibitor ketoconazole (>94%) but not by inhibitors of other P450 enzymes (<or=10%). Studies with a panel of cDNA-expressed enzymes revealed that M1 formation was catalyzed primarily by CYP3A enzymes at FTP concentrations <or=1 microM. M1 formation was catalyzed by P450s 3A4, 3A5, and 3A7; in vitro intrinsic clearance values (Vmax/Km) were comparable for all three CYP3A enzymes. These results suggest that at pharmacologically relevant concentrations, biotransformation of FTP to M1 is mediated predominantly by CYP3A enzymes in the liver.Keywords
This publication has 14 references indexed in Scilit:
- Variability of CYP3A7 Expression in Human Fetal LiverJournal of Pharmacology and Experimental Therapeutics, 2005
- METABOLISM OF ALFENTANIL BY CYTOCHROME P4503A (CYP3A) ENZYMESDrug Metabolism and Disposition, 2004
- Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?Current Opinion in Pharmacology, 2004
- Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and ChildrenNew England Journal of Medicine, 2003
- Regulation of CYP3A5 by Glucocorticoids and Cigarette Smoke in Human Lung-Derived CellsJournal of Pharmacology and Experimental Therapeutics, 2003
- Impaired recovery of hypothalamic-pituitary-adrenal axis function and hypoglycemic seizures after high-dose inhaled corticosteroid therapy in a toddlerAnnals of Allergy, Asthma & Immunology, 2002
- Cytochrome P450 3AClinical Pharmacokinetics, 1999
- Expression of CYP3A in the Human Liver — Evidence that the Shift between CYP3A7 and CYP3A4 Occurs Immediately After BirthEuropean Journal of Biochemistry, 1997
- Expression and localization of CYP3A4 and CYP3A5 in human lung.American Journal of Respiratory Cell and Molecular Biology, 1997
- The human pharmacology of fluticasone propionateRespiratory Medicine, 1990